Evaxion A EVAX
NASDAQ EVAX
$2.75 -0.25 (-8.33%)
At close: Nov 9, 2026 · 4:00 PM EST

Evaxion A (EVAX) Net Margin (2023 - 2025)

Updated

Evaxion A (EVAX) recorded Net Margin of -102.38% in FY2025, up 213.62 percentage points from -316.00% in FY2024.

Analysis

Evaxion A (EVAX) Net Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, EVAX's Net Margin was -316.00% in FY2024 (+29992.22 pp) and -30308.22% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 0.83%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 24.24%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 28.01%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 20.69%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 37.28%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 29.27%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 19.55%
10 Evaxion A 17.56 Mn -48.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 61.64%
Jun 30, 2025 -13,056.76%
Dec 31, 2024 -2,974.59%
Sep 30, 2024 -64.14%
Jun 30, 2024 -4,024.68%
Mar 31, 2024 2,341.18%
Dec 31, 2023 -610.39%
API Access

Evaxion A Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=EVAX&period=max&api_key=YOUR_API_KEY